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Abstract
Choanoflagellates are considered to be the closest living unicellular relatives of metazoans. The genome of the
choanoflagellate Monosiga brevicollis contains a surprisingly high number and diversity of tyrosine kinases, tyrosine
phosphatases, and phosphotyrosine-binding domains. Many of the tyrosine kinases possess combinations of domains that
have not been observed in any multicellular organism. The role of these protein interaction domains in M. brevicollis kinase
signaling is not clear. Here, we have carried out a biochemical characterization of Monosiga HMTK1, a protein containing a
putative PTB domain linked to a tyrosine kinase catalytic domain. We cloned, expressed, and purified HMTK1, and we
demonstrated that it possesses tyrosine kinase activity. We used immobilized peptide arrays to define a preferred ligand for
the third PTB domain of HMTK1. Peptide sequences containing this ligand sequence are phosphorylated efficiently by
recombinant HMTK1, suggesting that the PTB domain of HMTK1 has a role in substrate recognition analogous to the SH2
and SH3 domains of mammalian Src family kinases. We suggest that the substrate recruitment function of the noncatalytic
domains of tyrosine kinases arose before their roles in autoinhibition.
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Introduction
The machinery necessary for phosphotyrosine-based signaling
in metazoans includes ‘‘writer’’ domains (tyrosine kinases),
‘‘readers’’ (SH2 and PTB domains), and ‘‘erasers’’ (tyrosine
phosphatases) [1,2,3]. Genome analyses suggest that ‘‘eraser’’
domains emerged earliest in evolution; examples of tyrosine
phosphatases can be found, for example, in the yeast S. cerevisiae.
Metazoans have large numbers of SH2, PTB, tyrosine kinase, and
tyrosine phosphatase domains, suggesting a concerted expansion
of the apparatus needed for phosphotyrosine signaling. Surpris-
ingly, the genome of the unicellular choanoflagellate Monosiga
brevicollis contains numbers of each of these domains that are
comparable to complex multicellular organisms [3,4,5]. Because
choanoflagellates are considered to be the closest living unicellular
relatives of metazoans [5,6,7], the Monosiga brevicollis genome
affords an important glimpse into the early evolution of tyrosine
kinases and phosphatases.
In addition to their catalytic domains, metazoan nonreceptor
tyrosine kinases (NRTKs) possess noncatalytic domains that are
important in kinase function [8,9,10]. For example, the SH3 and
SH2 domains of Src-family tyrosine kinases have two important
functions: they participate in intramolecular interactions that
regulate the kinase domain, and they target the enzyme to cellular
substrates by specific protein-ligand interactions [11,12]. Many of
the NRTKs in Monosiga brevicollis display combinations of domains
that are not observed in multicellular animals [2,3]. Among the
unique domain combinations are kinases containing C2, FYVE,
and PTB domains. These observations underscore the importance
of domain shuffling in the emergence of tyrosine kinase signaling.
Studies on two Src-related kinases from Monosiga brevicollis (MbSrc1
and MbSrc4) have suggested that the substrate targeting function
of the SH3 and SH2 domains evolved earlier than the ability of the
domains to engage in autoinhibitory interactions [13,14].
The Monosiga brevicollis genome contains fifteen HMTK kinases
[3]. (The name HMTK is an acronym for HM motif-containing
tyrosine kinase, so named because the conserved His-Arg-Asp
sequence within the catalytic loop is replaced by a His-Met
sequence in this family). Ten of the fifteen HMTK kinases contain
one or more PTB domains, which in multicellular organisms often
bind to phosphotyrosine-containing proteins [15]. The HMTK
kinases are of particular interest, because the PTB domains may
play analogous functions to the SH2 domains found in many
families of nonreceptor tyrosine kinases; for example, the PTB
domains may be involved in targeting the HMTK kinase domain
to cellular proteins for phosphorylation [3]. Thus, HMTK kinases
may represent an example of convergent evolution. In this paper,
we have cloned and characterized the PTB-containing HMTK1
kinase. We report that the enzyme is active, and that the PTB
domain binds to peptides that contain phosphotyrosine. HMTK1
preferentially phosphorylates a substrate containing a PTB ligand,
suggesting that this system represents an early example of substrate
targeting.
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19296Materials and Methods
Antibodies and other reagents
Anti-phosphotyrosine antibody (clone 4G10) was from Milli-
pore, anti-Flag M2 and anti-tubulin clone GTU-88 were from
Sigma, mouse monoclonal anti-His6 was from Covance, and anti-
GST was from Molecular Probes. Horseradish peroxidase-linked
sheep anti-mouse IgG antibodies were from GE Healthcare.
Leupeptin, aprotinin, PMSF, sodium vanadate, sodium fluoride,
pyruvate kinase/lactate dehydrogenase enzymes, reduced NADH,
ethanolamine, and EZview red anti-Flag M2 affinity gel were from
Sigma. Affi-gel 15 agarose was purchased from BioRad.
cDNA cloning and mutagenesis
The predicted sequence of HMTK1 (784 amino acids) was
obtained from the Joint Genome Institute gene model (NCBI
accession number: XM_001749555). The form of HMTK1 used
in this study was amplified by PCR from a M. brevicollis cDNA
library [16] using the 59 primer ATCATGGGCGTCTTT-
GAAGCCACC and the 39 primer GCTCTAGATCAA-
TTCCTGTGCC-ATGTTGGCAAAGGATGGGCG. The 59
primer binds at the start of the third PTB domain of HMTK1
(residue 341); we were not successful in amplifying a cDNA using
primers at the 59 end of the gene model, or at the beginning of the
first or second PTB domains. The 39 primer extends to Leu 761 of
the predicted sequence. PCR reactions using a 39 primer based on
the entire 784 amino acids were unsuccessful. Thus, the 23 C-
terminal amino acids from the gene model are missing. These
residues are not predicted to be in a conserved domain.
For expression in insect cells, HMTK1 DNA (encoding residues
341–761) was cloned into the EcoRI site of pFastbac-Hta
(Invitrogen). FLAG-tagged HMTK1 was expressed in mammalian
cells by subcloning into the BglII and BamHI sites of p3XFLAG-
CMV (Sigma). The DPTB version of this construct was prepared
by PCR amplification and subsequent recloning into the BamHI
and EcoRI sites of p3XFLAG-CMV. Site-directed mutagenesis of
FLAG-HMTK1 was carried out using the QuikChange kit
(Stratagene). To express the isolated third PTB domain (residues
341–474) in bacterial cells, this PCR fragment was cloned into the
EcoRI site of plasmid pGEX-4T-1 (GE Healthcare). All constructs
were confirmed by DNA sequencing.
Protein expression and purification
HMTK1 was expressed in Spodoptera frugiperda (Sf9) insect cells
using the Bac-to-Bac system (Invitrogen). Sf9 cells (800 ml) were
infected with HMTK1 baculovirus and harvested after three days.
Cells were lysed in a French pressure cell, and His-tagged
HMTK1 was purified using nickel-nitrilotriacetic acid resin
(Qiagen), as described previously [13]. Peak fractions were pooled
and concentrated in an Amicon Ultrafiltration device (molecular
weight cutoff: 30,000 daltons). The purified protein was stored in
40% glycerol at 220uC. The isolated PTB domain of HMTK1
was produced as a fusion with glutathione S-transferase (GST). E.
coli cells (1 liter) expressing the GST fusion protein were lysed in a
French pressure cell, and the GST-PTB protein was purified by
chromatography on a glutathione-agarose column (Molecular
Probes).
Tyrosine kinase assays
Kinase assays were performed by two methods. Initial activity
measurements were performed by the phosphocellulose paper
binding assay [17]. Reaction mixtures contained 20 mM Tris-HCl
(pH 7.4), 10 mM MgCl2, 0.2 mM ATP, [c-
32P]-ATP (30–
50 cpm/pmol), and varying amounts of HMTK1 and peptide
substrates. All peptide substrates were purified by high pressure
liquid chromatography and characterized by mass spectrometry
prior to use. The following substrates were used: c-Src peptide,
AEEEIYGEFEAKKKG; MbSTAT peptide, KKKASGYV-
MADIA; RTKB2 peptide 1, SEEVYGAVVDKKK; RTKB2
peptide 2, AEEVYEAIADKKK; SH2 binding substrates (varying
linker lengths), RRLEDAIYAAGGGGGEPPQpYEEIG, RRLE-
DAIYAAGEPPQpYEEIG, and RRLEDAIYAPQpYEEIG; SH2
control substrate, RRLEDAIYAAGGGGGEPPQFEEIG. Initial
rate kinetic measurements on the PTB ligand-containing substrate
(KKAEEEIYGEFEANFTNPVpYATLG) and on the Phe-con-
taining PTB control (KKAEEEIYGEFEANFTNPVFATLG) were
carried out using a continuous spectrophotometric assay [18].
Reactions were performed at 30uC in a final volume of 50 ml. The
reactions contained 100 mM Tris pH 7.4, 10 mM MgCl2,2m M
ATP, 1.5 mM phosphoenolpyruvate, 90 units/ml of pyruvate
kinase, 109 units/ml of lactate dehydrogenase, and 1.2 mg/ml of
NADH. For determination of Km values, the enzyme concentra-
tions were 0.3–0.5 mM and the peptide concentrations ranged
from 0–700 mM. Kinetic constants were determined by nonlinear
fitting to the [substrate] vs. velocity curves using GraphPad
Prism 4.
Peptide binding reactions
The PTB ligand-containing peptide, Phe-containing PTB
control, and pYEEI peptide (EPQpYEEIG) were linked to Affi-
Gel 15 resin (Bio-Rad) following the manufacturer’s protocols.
Purified HMTK1 or the isolated PTB domain were incubated for
1 hour at 4uC with the immobilized peptides. After binding, the
beads were washed 4 times with 1 ml of binding buffer (50 mM
Tris-HCl pH 7.5, 5 mM EDTA, 100 mM NaCl, 0.1% Triton X-
100, 1 mM DTT, 0.5 mM Na3VO4). Bound proteins were eluted
with SDS-PAGE loading buffer, separated by 10% SDS-PAGE,
and visualized either by Coomassie blue staining or by Western
blotting.
Biotinylation of HMTK PTB domain
The PTB domain of HMTK1 was cloned as an EcoR1
fragment into a modified pGEX (GE Healthcare Life Sciences)
bicistronic vector pGEX-4T-BiotinN to express the gene of
interest and the biotin ligase (BirA) in the same cell ([19]; Chan
et al., in press). This results in a GST-PTB fusion protein
biotinylated at the 10-residue acceptor sequence IFEAQKW-
MEWRggs (biotin target residue underlined; spacer sequence in
small case) that is part of the linker region between the GST and
PTB domains. The resulting pGEX-BiotinN-PTB construct was
transformed into E. coli BL21(DE3) cells for expression. GST-
biotin-PTB protein was purified using glutathione-agarose and
desalted using a PD-10 (GE Healthcare) gel filtration column.
Peptide array experiment
N-terminally acetylated 11-residue peptides were synthesized
using standard chemistry in situ (PepSpots) on cellulose based
matrix (Jerini Biotools). To ensure protein accessibility, each
peptide contained a 4-residue spacer consisting of a glycine and 3
b-alanines. All peptides were immobilized via their C-termini. To
assess synthesis reproducibility, six different phosphopeptide
sequences predicted for 14-3-3 binding were made in duplicate
in different rows on the array, and displayed less than 10%
standard error for 14-3-3 binding levels between identical
sequences. Prior to usage, peptide array membranes were washed
in binding buffer (20 mM Hepes pH 7.3, 137 mM NaCl, 5 mM
KCl, 0.05% Tween-20) and blocked with 5% filtered bovine
serum albumin in the same buffer. Recombinant biotinylated PTB
Substrate Targeting in a Unicellular Kinase
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BSA, and incubated with the array membrane for 30 min at
room temperature. After washing (2610 min), streptavidin-HRP
(1:20,000, GE) was added for 15 minutes at RT. After washing in
binding buffer (3610 min), bound PTB was detected using
enhanced chemiluminescence and standard X-ray film.
Cell transfections, immunoprecipitation and Western
blotting
SYF cells were cultured in Dulbecco’s modified Eagle’s medium
(Mediatech, Inc.) supplemented with 10% fetal bovine serum
(Sigma) and 1000 UI/ml penicillin, 1000 UI/ml streptomycin and
25 ng/ml amphotericin B (Mediatech, Inc.). SYF cells (2.25610
6)
were plated in 15-cm diameter dishes and transfected after
24 hours using 5–15 mg of DNA and 2 ml TransIT per mg DNA.
After 48 hours, the cells were harvested, washed twice with PBS
and lysed using radioimmune precipitation assay (RIPA) buffer
(50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 1%
sodium deoxycholate, 1% Nonidet P-40) supplemented with the
protease inhibitors leupeptin (10 mg/ml), aprotinin (10 mg/ml),
PMSF (200 mM) and the phosphatase inhibitors Na3VO4
(0.2 mM) and NaF (10 mM). Lysates (50 mg) were separated by
10% SDS-PAGE, transferred to PVDF membranes and probed
with the appropriate antibodies. For immunoprecipitation, cell
lysates (100 mg) were incubated overnight at 4uC with 40 mlo f
EZview red anti-Flag M2 affinity gel pre-equilibrated with RIPA
buffer in a total volume of 1 ml. The immunocomplexes were
washed 4 times, eluted from the beads by adding Laemmli buffer,
separated by SDS-PAGE, transferred to PVDF membranes and
probed with the appropriate antibodies.
Results
The predicted amino acid sequence of M. brevicollis HMTK1
contains three PTB domains and a C-terminal tyrosine kinase
catalytic domain (Fig. 1A). We amplified a cDNA encoding residues
Ile341-Leu761 by PCR from an M. brevicollis cDNA library. This
construct contains the third PTB domain plus the kinase domain, and
lacks the predicted C-terminal 23 amino acids (Fig. 1B). We were
unable to amplify cDNAs encoding the first or second PTB domains,
or the extreme C-terminus, suggesting that these longer forms are not
expressed, at least under the conditions used to generate the cDNA
library. There is a predicted intron/exon boundary in the HMTK1
gene two codons upstream of the third PTB, raising the possibility
that this single-PTB form of HMTK1 is expressed.
The third PTB domain shows highest homology to the Gulp
and Numb PTB domains (e.g., 31% amino acid identity with the
mouse Gulp-2 protein). The kinase domain is most closely related
to the fibroblast growth factor receptor-1 tyrosine kinase (39%
amino acid identity with the human FGFR1; Figure S1). HMTK1
possesses most of the catalytically important sequence elements
that are conserved across the protein kinase superfamily. HMTK1
has the kinase-conserved DFG motif (at Asp647) that is involved in
ATP binding. The predicted activation loop of HMTK1 contains
a single tyrosine (Tyr660, in the sequence EGDQYWQSK), with
the N-terminal residues to the tyrosine typical for autopho-
sphorylated acidophilic kinases. However, the conserved HRD
motif in the catalytic loop is replaced with HMD (Fig. 1B). The
arginine within the HRD motif typically interacts with phosphate
in protein kinases that are regulated by activation loop
phosphorylation [20,21]; however, it is possible that the HMTK1
His residue could play an analogous role.
To test whether HMTK1 is enzymatically active, we cloned the
HMTK1 DNA into a baculovirus expression vector and expressed
the enzyme in Spodoptera frugiperda (Sf9) cells. We purified the His-
tagged PTB-kinase construct using nickel-nitrilotriacetic acid resin.
For our initial enzymatic characterization, we measured phos-
phorylation of an acidophilic Src peptide (AEEEIYGE-
FEAKKKKG) [22] using
32P-labeled ATP (Fig. 1C). HMTK1
phosphorylated this peptide efficiently, and the activity showed the
expected dependence on enzyme concentration. HMTK1 dis-
played no activity toward peptide substrates for Ser/Thr-protein
kinases (data not shown), confirming that it is a tyrosine-specific
protein kinase. Next, we compared phosphorylation of this peptide
with peptides derived from putative M. brevicollis kinase substrates.
Two of the peptides (RTKB2 peptides 1 and 2) correspond to
sequences from the intracellular domain of a M. brevicollis receptor
tyrosine kinase, and the third (MbSTAT) is from a putative M.
brevicollis STAT [3]. HMTK1 showed highest activity towards
peptide RTKB2 peptide 2, roughly equivalent activity towards
RTKB2 peptide 1 and the c-Src substrate peptide, but no
significant activity towards MbSTAT (Fig. 2A). The two Monosiga
kinases previously characterized (MbSrc1 and MbSrc4) had
substantially higher activities towards RTKB2-1 and RTKB2-2
compared with the c-Src peptide [13,14], suggesting that the
kinase domains possess a measure of intrinsic substrate specificity.
By anti-phosphotyrosine Western blotting, the preparation of
HMTK1 shows evidence of phosphorylation (Fig. S2). (This could
be due to HMTK1 autophosphorylation, or to phosphorylation by
endogenous Sf9 cell kinases). Treatment of purified HMTK1 with
Yersinia tyrosine phosphatase led to a decrease in phosphoryla-
tion. Incubation of HMTK1 with ATP and MgCl2 under
conditions that typically promote autophosphorylation of tyrosine
kinases (e.g., [23]) did not increase the pTyr signal, suggesting that
the autophosphorylation activity of HMTK1 is relatively weak.
We measured HMTK1 activity toward a series of peptide
substrates which incorporated the Src SH2 ligand pYEEI. For Src-
family kinases, the presence of the pYEEI sequence leads to a
<10-fold reduction in peptide Km, due to SH2 domain-mediated
targeting [24]. A substrate peptide possessing the pYEEI sequence
was phosphorylated 5-fold more strongly than a control sequence
lacking phosphotyrosine or a shortened peptide containing only
the substrate motif (Fig. 2B). These results suggest that the PTB
domain of HMTK might recognize pYEEI. The SH2-binding
substrate used in Fig. 2B had a spacer of 11 residues between the
pYEEI sequence and the phosphorylatable tyrosine. We tested
HMTK1 with peptides containing shorter linker lengths, but we
did not observe preferential phosphorylation of these peptides
relative to the control (Fig. 2B); this result is similar to results with
Src-family kinases [24].
We tested whether HMTK1 could interact with phosphotyrosine
in a direct binding assay with immobilized pYEEI (Fig. 3A). Purified
HMTK1 (or as a positive control, purified Src) was mixed with
pYEEI peptide that had been attached to Affi-Gel 15 resin. Both
HMTK1 and Src bound to pYEEI in this experiment, but did not
interact with the Affi-Gel control resin. We confirmed that the
pYEEI-binding activity was localized to the PTB domain by using the
isolated PTB domain in a pulldown assay (Fig. 3B). We produced a
version of HMTK1 lacking the PTB domain (DPTB). FLAG-tagged
forms of wild-type HMTK1 and DPTB were expressed in triple Src/
Yes/Fyn-knockout (SYF) cells[25], and lysates wereused inpulldown
experiments. Wild-type HMTK1 bound to immobilized pYEEI,
while DPTB did not (Fig. 3C). HMTK1 failed to bind to an
immobilized phosphoserine-containing peptide (phospho-Kemptide,
LRRApSLG), suggesting that the negatively charged phosphate of
pYEEI was not the sole binding determinant.
In the next series of experiments, we tested whether HMTK1
possesses tyrosine kinase activity towards mammalian protein
Substrate Targeting in a Unicellular Kinase
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reduce background phosphorylation. For comparison, we also
expressed DPTB, as well as two point mutants containing amino
acid substitutions that could potentially disrupt PTB-phosphotyr-
osine interactions (Figure S3). Anti-phosphotyrosine Western
blotting of SYF cell lysates showed no significant activity for
HMTK1 (wild-type or mutants) over the background levels seen in
untransfected SYF cells (Figure S4A). Treatment of SYF cells with
sodium orthovanadate enhanced overall phosphorylation, but no
difference was apparent between untransfected and HMTK1-
kinase
Figure 1. Monosiga brevicollis HMTK1 kinase. (A) Domain arrangement of HMTK1. (B) Amino acid sequence of the PTB-kinase HMTK1 construct
used in this study. The HMD motif in the catalytic loop is underlined. (C) Tyrosine kinase activity of HMTK1. Purified HMTK1 (at the indicated
concentrations) was assayed with the c-Src peptide (500 mM). Reactions proceeded for 6 minutes at 30uC, and enzyme activity was measured using
the phosphocellulose paper assay.
doi:10.1371/journal.pone.0019296.g001
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containing proteins in SYF cells bound to HMTK1, we isolated
HMTK1 and associated proteins using FLAG beads and analyzed
them by anti-pTyr Western blotting. We did not observe any
significant pTyr-containing bands in these experiments (Figure
S5). Expression of HMTK1 in COS-7 cells gave similar results
(data not shown). Because there was no evidence for HMTK1
autophosphorylation, HMTK1 may not be phosphorylated in the
activation loop to significant levels. Thus, although HMTK1
possesses intrinsic tyrosine kinase activity (Figs. 1 and 2), its activity
in mammalian cells is undetectable by standard anti-phosphotyr-
osine Western blotting.
Different metazoan PTB domains have different ligand prefer-
ences [26], and it is not currently possible to predict PTB specificity
from amino acid sequence alone [15]. The third PTB domain of
HMTK1 bound to the typical SH2 ligand pYEEI (Fig. 3), although
thissequencedoes not conform to thetypicalPTBligand.To search
morebroadlyforHMTK1PTBligands,wecarried outexperiments
using a peptide array with multiple potential PTB ligands. The PTB
domain was biotinylatedby co-expression with biotin ligase in E. coli
[19]. Purified biotinylated PTB domain was then used to probe a
membrane on which 30 potential binding peptides had been
immobilized (Fig. 4A). The peptide sequences in Fig. 4B include
phosphorylated and unphosphorylated counterparts known as
targets for different classes of mammalian PTB domains [26]. This
experiment identified several HMTK1 PTB3 binding sequences.
Some peptides (e.g., spots 1–2) bound with similar affinity in their
phosphorylated and unphosphorylated states. Other peptide pairs
(e.g., spots 7–8, 11–12, 15–16) showed stronger binding when
tyrosine phosphorylated (Fig. 4A).
We selected a pair of peptides for further study. The peptides
(spots 15–16, containing the sequence TNFTNPVYATG, derived
from the low density lipoprotein-3 receptor), showed binding to the
biotinylated PTB domain that was strongly phosphotyrosine-
dependent (Fig. 4A). We synthesized an individual peptide in which
the sequence NFTNPVpYATG was connected to a tyrosine kinase
substratesequence.Asacontrol,weprepareda peptideinwhich the
pTyr residue was replaced with Phe (we did not use Tyr in the
control sequence to avoid complications due to a second
phosphorylatable tyrosine in the substrate). We immobilized the
two peptides on Affi-Gel resin, and tested binding to the purified
HMTK1 protein. HMTK1 bound to the pTyr-containing
sequence, but binding to the Phe-containing control peptide was
undetectable (Fig. 5A). Next, we carried out substrate targeting
experiments similar to those shown above in Fig. 2B and C.
HMTK1 preferentially phosphorylated the pTyr-containing pep-
tide as compared to the control (Fig. 5B). Steady-state kinetic
analyses of these peptides gave a Km value of 33 mM for the pTyr
peptide and 450 mM for the Phe peptide. The value of Vmax for the
pTyr-peptide (4.9 mmol/min/mg enzyme) is comparable to the
value for Src family kinases with the same peptide (e.g., Hck, with
Vmax=3.0 mmol/min/mg enzyme [24]). The difference in Km
values between pTyr- and Phe-containing peptides is comparable to
the well-studied effect of the SH2 domain in Src kinase substrate
recognition [24,27], suggesting that the PTB domain of Monosiga
brevicollis HMTK1 may function as a substrate targeting module.
Discussion
Metazoan nonreceptor tyrosine kinases invariably possess
noncatalytic modular domains in addition to their conserved
catalytic domains. These noncatalytic regions play important roles
in subcellular localization, enzymatic regulation, protein-protein
interactions, and substrate recognition [8]. The kinome of the
choanoflagellate Monosiga brevicollis likewise shows numerous
examples of tyrosine kinase catalytic domains connected to
modular signaling domains [2,3]. Strikingly, many of the domain
combinations found in Monosiga have not been seen elsewhere,
including in metazoans. The noncatalytic regions of these kinases
presumably have important functional roles, similar to their
metazoan counterparts.
Here,wehavecarried outa biochemicalstudyofone suchkinase,
HMTK1. Ten of the fifteen Monosiga HMTK kinases contain at
Figure 2. Additional HMTK1 peptide phosphorylation assays. Reactions proceeded for 6 minutes at 30uC, and enzyme activity was measured
using the phosphocellulose paper assay. (A) Phosphorylation of a c-Src peptide and Monosiga-derived peptides (750 mM) by purified HMTK1
(400 nM). The sequences are: c-Src peptide, AEEEIYGEFEAKKKG; MbSTAT peptide, KKKASGYVMADIA; RTKB2 peptide 1, SEEVYGAVVDKKK; RTKB2
peptide 2, AEEVYEAIADKKK. (B) Phosphorylation of SH2-binding substrates containing various spacer lengths between the pY residue and the
phosphorylatable tyrosine. The peptides are shown schematically, with the phosphorylation site in blue, the SH2-binding ligand (pYEEI) in red, and
the number of intervening amino acids in a box. The sequences of the peptides are: RRLEDAIYAAGGGGGEPPQpYEEIG (spacer=11),
RRLEDAIYAAGEPPQpYEEIG (spacer=7), and RRLEDAIYAPQpYEEIG (spacer=3); SH2 control substrate, RRLEDAIYAAGGGGGEPPQFEEIG (spacer=11);
substrate peptide, RRLEDIAYAAG. Reactions contained 70 mM peptides. Error bars show standard deviation.
doi:10.1371/journal.pone.0019296.g002
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may not fold into a functional unit. Although the number of PTB
domains varies in this family (1–3 domains), it is noteworthy that the
PTB domains all lie N-terminal to the kinase domains, i.e., in the
same relative position as SH2 domains and kinase domains in Src-
family kinases. In Src, the positioning of the SH2 domain relative to
the kinase domain plays a role in substrate recognition [28]. A
mutant form of Src in which the SH2 domain was placed C-
terminal to the catalytic domain showed decreased phosphorylation
of Cas and Sam68 in cells, and decreased phosphorylation of
pYEEI-containing peptide substrates in vitro [28].
The combination of a PTB and a tyrosine kinase domain is not
found in higher metazoans. On the other hand, the individual
PTB and kinase domains of HMTK1 show sequence conservation
with related domains from metazoans. The third PTB domain of
HMTK1 (as well as the first and second PTB domains, not studied
here) are related to the Numb and Gulp families of PTB domains
(Fig. S3). PTB domains from other Monosiga HMTK kinases (e.g.,
HMTK4, HMTK8) show the most similarity to these same
families of PTB domains, suggesting that HMTK1 is fairly typical
of the family in this regard. The HMTK1 catalytic domain is most
closely related to mammalian receptor tyrosine kinase domains.
We confirmed that HMTK1 possesses tyrosine kinase activity
by expressing the protein in insect cells, purifying it, and
measuring phosphorylation of synthetic peptides. To examine
HMTK1 activity in intact cells, we turned to a heterologous cell
system (mammalian SYF fibroblasts), due to the difficulties
associated with expressing genes in Monosiga. The activity of
HMTK1 was undetectable in these cells (Fig. S3). We also
explicitly tested the mammalian receptor tyrosine kinases ErbB2
and IGF1R as potential binding partners, but HMTK1 failed to
bind or phosphorylate these proteins when co-expressed with them
(data not shown). One possible explanation is that the substrate
specificity of HMTK1 is tuned to proteins in Monosiga cells, rather
than mammalian proteins. Alternatively, the protein may adopt a
low-activity conformation in mammalian cells through autoinhi-
bitory interactions, or though interactions with other cellular
proteins. (For example, HMTK1 may normally require activation
by other Monosiga kinases which are absent in mammalian cells,
and the high activity of mammalian tyrosine phosphatases would
repress HMTK1 activity). Our data cannot distinguish between
these possibilities at present.
We carried out experiments with immobilized peptide arrays to
search more broadly for HMTK1 binding partners. Pawson and
coworkers previously used NPXY peptide arrays to screen for
binding partners for 10 diverse PTB domains [26]. The results
showed a variety of pTyr-dependent and pTyr-independent
interactions with the various classes of PTB domains. For our
experiments, we selected representative peptide sequences that
bound to the different classes of PTB domains. We included
Figure 3. Binding reactions with pYEEI-containing peptide. (A). Purified HMTK1 or c-Src (20 mg) were mixed with 30 ml of immobilized pYEEI
peptide (pY) or control resin (C) in total volumes of 175 ml for 1 hour at 4uC. After binding, the resins were washed 4 times with 200 ml of binding
buffer. Bound proteins were eluted with SDS-PAGE sample buffer and analyzed by gel electrophoresis with Coomassie blue staining. (B). The isolated
HMTK1 PTB domain (8 mg) was incubated with 50 ml of immobilized pYEEI peptide (pY) or control resin (C) in total volumes of 400 ml for 1 hour at
4uC. After washing, bound proteins were eluted with SDS-PAGE sample buffer and analyzed by Western blotting with anti-GST antibody. (C). Lysates
from SYF cells expressing FLAG-tagged wild-type or DPTB forms of HMTK1 were incubated with immobilized pYEEI peptide (pY), phospho-Kemptide
(pS), or control resin. After washing, bound proteins were analyzed by anti-FLAG Western blotting. The input lanes show lysates (corresponding to
20% of the amounts used for pulldowns) loaded directly on the gel.
doi:10.1371/journal.pone.0019296.g003
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tyrosine. Because our preliminary data showed binding of the
HMTK1 PTB domain to the sequence pYEEI, which is found in
the polyoma virus middle T antigen, we also included the wild-
type middle T sequence and several variants within the YEEI
motif. The HMTK1 PTB domain bound to many of the peptides
in the array (Fig. 4). Several of the NPXY-type sequences bound
more strongly to the HMTK1 PTB than the pYEEI sequence.
Some of the sequences did not show significant pTyr-dependence,
probably due to a high background from hydrophobic interac-
tions. We examined one sequence (TNFTNPVYATLG, derived
from the LRP3 receptor) which bound much more strongly in the
phosphorylated state. We showed that a synthetic peptide
containing this sequence (with pTyr) bound to the longer
PTB-kinase construct of HMTK1 (Fig. 5A). Furthermore, we
demonstrated that this peptide was phosphorylated more efficient-
ly than a control in which pTyr was replaced by Phe (Fig. 5B). The
presence of pTyr led to a <15-fold reduction in peptide Km, which
is comparable to the effects of the pYEEI motif recognized by the
Src SH2 domain.
These results suggest that the role of the HMTK1 PTB domain
may be to target the enzyme to potential substrates in Monosiga
brevicollis cells. To identify potential substrates, we searched for
occurrences of the TNFTNPVYATLG motif within the Monosiga
genome using the protein-translated nucleotide BLAST search tool
on the genome site (http://genome.jgi-psf.org/Monbr1/Monbr1.
home.html). Although there were no matches to the full sequence,
two predicted proteins had partial matches. Gene model number
11339 encodes a predicted transmembrane protein with cadherin
and SH2 domains; the predicted protein includes a FSNPMYA
sequence. A second SH2-containing Monosiga protein (gene model
number 34447) contains the sequence NPVYA. We carried out a
similar analysis using other PTB-binding peptides from the array
experiment. The sequence EYGEL from Monosiga RTKB8 was
identified by a search using peptides 11/12 (Fig. 4A), with the
sequence QVFYNSEpYGEL. It will be interesting to determine
whether these proteins are phosphorylated in Monosiga cells.
Many metazoan Ser/Thr and Tyr protein kinases recruit their
substrates via interactions with secondary binding sites (i.e., apart
from the kinase catalytic domain). MAP kinases, for example,
Figure 4. Peptide array experiment. (A) A PepSpots array containing 30 immobilized peptides was probed with purified biotinylated HMTK1 PTB
domain. Bound PTB domain was detected using streptavidin-HRP and enhanced chemiluminescence. Exposures from 10 and 30 seconds are shown
for dynamic range comparisons. Peptides 15 and 16, selected for further study, are indicated with red arrowheads. (B) Sequences of the immobilized
tyrosine- and phosphotyrosine-containing peptides. The proteins from which the peptides are derived are listed to the right of the sequences.
Peptides 17–28 contain the polyoma middle T (PymT) sequence (wild-type and single amino acid variants). Peptides 15–16 from LRP3, chosen for
further study, are shown in bold.
doi:10.1371/journal.pone.0019296.g004
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In nonreceptor tyrosine kinases, several modular protein-protein
interaction domains have been found to influence substrate
specificity, including SH2, SH3, PH, F-actin binding, and focal
adhesion binding domains. The results reported here for the
primitive kinase HMTK1 expand the list to include PTB domains,
and together with previous results for MbSrc1 [13] and MbSrc4
[14], suggest that the domain architectures in tyrosine kinases
evolved first to fill this substrate recruitment function. Further
evolutionary fine-tuning of the domain arrangements was
necessary to establish the elaborate mechanisms of regulation
needed in metazoan signaling pathways.
Supporting Information
Figure S1 Sequence alignment of the kinase domains of
HMTK1 and human fibroblast growth factor receptor 1.
The HRD/HMD sequences in the catalytic loop are underlined,
and the tyrosine residue in the predicted activation loop is shown
in red.
(EPS)
Figure S2 Autophosphorylation of HMTK1. Purified
HMTK1 (36 ng) was analyzed by anti-pTyr Western blotting
after incubation with Yersinia tyrosine phosphatase (+YOP), with
no treatment (HMTK), or after an autophosphorylation reaction
(+ATP). The autophosphorylation reaction contained 1 mM ATP
and 10 mM MgCl2, and proceeded for 45 minutes at 30uC.
(EPS)
Figure S3 Structural model of HMTK1 PTB. A homology
model of the third PTB domain of HMTK is shown, based on the
human Numb-R protein [30]. We identified Numb-R as the
closest relative to the third PTB domain of HMTK using HMM-
HMM comparisons (http://toolkit.tuebingen.mpg.de/hhpred).
Numb-R contains two Phe residues that are important for ligand
binding [31], and the two Phe residues are conserved at equivalent
positions (F71 and F117) in the HMTK PTB domain.
(EPS)
Figure S4 Expression of HMTK1 in mammalian cells.
(A). SYF cells were transfected with FLAG-tagged HMTK1 (wild-
type, DPTB, or mutant forms, as indicated). Whole cell lysates
were analyzed by SDS-PAGE and Western blotting with anti-
Figure 5. Substrate targeting by PTB ligand. (A) Purified HMTK1 (6.6 mg) was incubated with PTB ligand-containing substrate
(KKAEEEIYGEFEANFTNPVpYATLG), PTB control substrate (KKAEEEIYGEFEANFTNPVFATLG), pYEEI peptide, or control resin in final volumes of 60 ml.
After washing, bound proteins were eluted with SDS-PAGE sample buffer and analyzed by Western blotting with anti-His6-tag antibody. (B) The
kinase activity of HMTK1 (300 nM) toward the PTB ligand-containing substrate or PTB control substrate (shown schematically) was determined using
the phosphocellulose paper assay. The reaction contained 20 mM Tris-HCl (pH 7.4), 10 mM MgCl2, 0.2 mM ATP, 30 mM peptide, and [c-
32P]-ATP. At
each time point, an aliquot was withdrawn and 10% trichloroacetic acid was added to stop the reaction. Incorporation of
32P into the peptides was
determined by scintillation counting.
doi:10.1371/journal.pone.0019296.g005
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C=untransfected SYF cells. The figure is representative of 4
experiments. (B) Similar experiments were carried out on control
or HMTK1-transfected SYF cells treated with 0. 0.1, or 1.0 mM
sodium orthovanadate (20 minutes, 37uC) prior to lysis. Similar
amounts of lysates were used in panels (A) and (B), but a shorter
exposure time was used in (B) than in panel (A).
(EPS)
Figure S5 Immunoprecipitation experiment. HMTK1
(wild-type or mutants) was immunoprecipitated from SYF cells
using anti-FLAG affinity resin. Proteins in the immunocomplexes
were separated by SDS-PAGE and analyzed by Western blotting
with anti-pTyr and anti-FLAG antibodies. The band at <110 kDa
is a non-specific band. The figure is representative of 3
experiments.
(EPS)
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